In conclusion, the TMPRSS2 gene is highly expressed in normal prostate tissues and increased significantly in PRAD cancer tumours, indicating the susceptibility for the SARS‐CoV‐2 infection and high severity of COVID‐19 symptoms. This evidence concerns the gene TMPRSS2 and prostate adenocarcinoma.